Marvel Biosciences

Marvel Biosciences Corp. and its wholly-owned subsidiary, Marvel Biotechnology Inc., is a Calgary-based preclinical stage drug development biotechnology company that adopts a "drug repurposing" approach for drug development. Marvel develops new synthetic chemical derivatives of originally approved drugs for new disease indications. The company seeks patent protection as the new potential assets are developed in-house. The company believes this business model significantly reduces the risks, costs, and time associated with developing its assets compared to traditional biotechnology companies.